$1.70
1.19% yesterday
Nasdaq, Nov 25, 09:58 pm CET
ISIN
US89532E1091
Symbol
TRVN
Sector
Industry

Trevena, Inc. Stock price

$1.70
-0.29 14.57% 1M
-8.30 83.00% 6M
-16.35 90.58% YTD
-12.43 87.96% 1Y
-452.30 99.63% 3Y
-429.55 99.61% 5Y
-3,523.30 99.95% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.02 1.19%
ISIN
US89532E1091
Symbol
TRVN
Sector
Industry

Key metrics

Market capitalization $1.47m
Enterprise Value $25.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 45.98
P/S ratio (TTM) P/S ratio 2.67
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -82.94%
Revenue (TTM) Revenue $550.00k
EBIT (operating result TTM) EBIT $-32.11m
Free Cash Flow (TTM) Free Cash Flow $-27.11m
Cash position $13.74m
EPS (TTM) EPS $-46.91
P/E forward negative
P/S forward 2.45
EV/Sales forward 42.15
Short interest 7.03%
Show more

Is Trevena, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Trevena, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Trevena, Inc. forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Trevena, Inc. forecast:

Buy
50%
Hold
50%

Financial data from Trevena, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.55 0.55
83% 83%
100%
- Direct Costs 2.09 2.09
55% 55%
380%
-1.54 -1.54
183% 183%
-280%
- Selling and Administrative Expenses 17 17
16% 16%
3,076%
- Research and Development Expense 13 13
16% 16%
2,387%
-32 -32
6% 6%
-5,745%
- Depreciation and Amortization 0.51 0.51
30% 30%
93%
EBIT (Operating Income) EBIT -32 -32
7% 7%
-5,837%
Net Profit -34 -34
11% 11%
-6,185%

In millions USD.

Don't miss a Thing! We will send you all news about Trevena, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trevena, Inc. Stock News

Neutral
GlobeNewsWire
19 days ago
CHESTERBROOK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today reported its financial results for the third quarter ended September 30, 2024 and provided an overview of its recent operational updates.
Neutral
GlobeNewsWire
about 2 months ago
CHESTERBROOK, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that on October 4, 2024 the Company received notice that the Nasdaq Hearings Panel (the “Panel”) had determined to delist the Company's common s...
Neutral
GlobeNewsWire
5 months ago
Trevena expects to receive a non-dilutive $2 million tranche and may be eligible for up to an additional $8 million based on OLINVYK US partnering and commercialization milestones
More Trevena, Inc. News

Company Profile

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Carrie Bourdow
Employees 23
Founded 2007
Website www.trevena.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today